Showing 1 - 3 of 3
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Published on 24/05/2021
» •Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in ongoing pivotal Phase 3 TIDES trial • Regulatory filings for TAK-003 progressing in European Union and in many dengue-endemic countries; filing in United States planned for later this year • Dengue is the fastest-spreading mosquito-borne viral disease with an estimated 390 million cases and 500,000 hospitalizations per year globally, with limited options for prevention
BDMS Wellness Clinic joins hands with OHSU towards “Heart Longevity”
Published on 07/02/2020
» BDMS Wellness Clinic, a leading preventive healthcare clinic, in collaboration with Oregon Health & Science University (OHSU), Oregon, Unites States, presents “Heart Longevity”
EVA’s Message is “Taipei, Your Best Gateway to Asia”
Published on 11/11/2019
» Airline posts new marketing slogan on high-visibility electronic boards at global locations including New York’s Times Square.